(Q38155666)

29 August 2017

title

The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy (English)

1 reference

29 August 2017

main subject

neoplastic stem cells

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24161136%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

Claudio Tiribelli

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24161136%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

author name string

Caecilia H C Sukowati

series ordinal

1

1 reference

29 August 2017

Claudio Tiribelli

series ordinal

2

1 reference

29 August 2017

publication date

1 November 2013

1 reference

Expert Review of Gastroenterology & Hepatology

29 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24161136%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24161136%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24161136%20AND%20SRC:MED&resulttype=core&format=json

3 June 2020

page(s)

749-757

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24161136%20AND%20SRC:MED&resulttype=core&format=json

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

3 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Estimating the world cancer burden: Globocan 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Significance of CD90+ cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Identification of local and circulating cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

CD13 is a therapeutic target in human liver cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Induction of cancer cell stemness by chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Characterization of a side population of cancer cells from human gastrointestinal system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Cancer stem cells in human gastrointestinal cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Gene expression profiling of liver cancer stem cells by RNA-sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Efficacy of using cancer stem cell markers in isolating and characterizing liver cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Dynamic signaling network for the specification of embryonic pancreas and liver progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Tissue repair and stem cell renewal in carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Activation of the hedgehog pathway in human hepatocellular carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Clinical implications of microRNAs in liver cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Mesenchymal Stem or Stromal Cells: Toward a Better Understanding of Their Biology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

A high-throughput cell-based assay for inhibitors of ABCG2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

3-Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor-initiating hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

Novel therapeutic target for cancer stem cells in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826

HCC surveillance: Who is the target population?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2013.846826